BioLaw practice includes Legislative Initiatives, Policy Development and Analysis.
Turning ideas into effective public policy requires more than advocacy—it requires a thoughtful, informed strategy. Many organizations and nonprofits have innovative programs and long-term goals but struggle to navigate the legislative process, understand where decisions are made, and determine how to engage in a meaningful, appropriate way.
BioLaw Group focuses on careful policy development and analysis, not lobbying or marketing. We work with clients to shape initiatives, evaluate legal and regulatory frameworks, and design clear, actionable policy strategies that align with their mission. Our experience includes national work developing model legislation for assisted reproduction designed for consideration across all 50 states, reflecting legal complexity, evolving medical practice, and respecting nuanced ethical underpinnings.
With extensive experience at both the state and national levels, BioLaw Group understands how elected officials and regulators approach complex issues. We help clients understand the nuances of the process—who to engage, when to engage, and how to present ideas effectively—so they can participate with confidence and clarity rather than remaining on the sidelines.
Jaeger has navigated many firsts: first case naming same sex couple as parents without an adoption; prevailing in challenge attempting to ban IVF as unconstitutional experimentation. Below in additional recources include EEOC policy to protect employee’s genetic information based on Jaeger’s research, eventually leading to the passage of GINA; and developing model legislation for assisted reproduction.
